Please assess the completion status of the following clinical trial:

Trial Title: Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Age between 18 and 75 years~* Rheumatoid arthritis according to the American College of Rheumatology (ACR) criteria 1987 or ACR/European Liga Against Rheumatology (EULAR)2010~* Disease activity score (DAS) 28 \> 2.6~Main Exclusion Criteria:~* Prior or other current subcutaneous treatment with self-injection~* Prior or concomitant treatment with biologics~* Contraindications to MTX treatment~* History or diagnosis of a dermatological disease at the injection site~* Women with child-bearing potential who do not use a highly effective method of contraception or men who have a partner with child-bearing potential and do not use a contraception during the study and at least 6 months thereafter.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- prefilled pen then prefilled syringe (Type: OTHER): weekly methotrexate injection with a prefilled pen during 3 weeks and subsequently with the prefilled syringe the last 3 weeks
- prefilled syringe then prefilled pen (Type: OTHER): weekly methotrexate injection with a prefilled syringe during 3 weeks and subsequently with the prefilled pen the last 3 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).